Case Western, TGen to Use Affy Arrays in Diabetes Study | GenomeWeb
NEW YORK (GenomeWeb News) – Case Western Reserve University and the Translational Genomics Research Institute will use Affymetrix’s Human SNP Array 6.0 to study genetic pathways associated with a certain complication of diabetes, Affy said today.
 
The two institutions will use Affy’s arrays to focus on finding genetic links to diabetic nephropathy using data from a study by the National Institute of Diabetes and Digestive and Kidney Diseases.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.